The potential role of derma‐venereologists in prescribing and managing pre‐exposure prophylaxis in Italy-Reference-Cited by-同舟云学术

The potential role of derma‐venereologists in prescribing and managing pre‐exposure prophylaxis in Italy

Published:2024-08-06 Issue: Volume: Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Pisano L.¹^ORCID,Ciccarese G.²^ORCID,Balestri R.³,Gaspari V.⁴,Ramoni S.⁵^ORCID,Atzori L.⁶^ORCID,Papini M.⁷

Affiliation:

1. Section of Dermatology, Health Sciences Department University of Florence Florence Italy

2. Section of Dermatology, Department of Medical and Surgical Sciences University of Foggia Foggia Italy

3. Division of Dermatology U.O. Multizonale APSS Trento Italy

4. Dermatology Unit IRCCS Azienda Ospedaliero‐Universitaria di Bologna Bologna Italy

5. Dermatology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

6. Unit of Dermatology, Department Medical Sciences and Public Health University of Cagliari Cagliari Italy

7. Department of Medicine and Surgery University of Perugia, Dermatology Clinic of Terni Terni Italy

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.20278

Reference10 articles.

1. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial

2. The Joint United Nations Programme on HIV/AIDS (UNAIDS).Sustainable Development Strategy 2016–2021.

3. Agenzia Italiana del Farmaco.Determina 10 agosto 2017 n. 1483 ‐ Nuove indicazioni terapeutiche del medicinale per uso umano «Truvada» non rimborsate dal Servizio sanitario nazionale. Gazzetta Ufficiale Serie Generale n. 203/2017.

4. Agenzia Italiana del Farmaco.Determina 8 maggio 2023 n. 349/2023 ‐ Regime di rimborsabilità e prezzo a seguito di nuove indicazioni terapeutiche del medicinale per uso umano «Emtricitabina/Tenofovir Disoproxil Mylan». GU Serie Generale n.115 del 18‐05‐2023.